Top Companies in Mass Spectrometry Market

The mass spectrometry market is projected to grow from USD 7,074.0 million in 2026 to USD 10,783.3 million by 2031, at a CAGR of 8.8% during this period. The global mass spectrometry market is witnessing strong growth driven by the increasing adoption of precision medicine, companion diagnostics, and biomarker-based drug development strategies across the pharmaceutical and biotechnology industries. Advances in genomic sequencing and disease biomarker identification are accelerating the demand for highly sensitive analytical technologies capable of accurate molecular characterization and quantification. As pharmaceutical companies increasingly shift toward patient-stratified therapies, mass spectrometry, particularly LC-MS/MS and GC-MS platforms, has emerged as a critical technology for biomarker discovery, proteomics, metabolomics, and clinical research applications.

Another major market trend is the growing emphasis on regulatory compliance and bioanalytical validation standards in drug development. Regulatory agencies such as the U.S. Food and Drug Administration are strengthening requirements for bioanalytical method validation under ICH M10 and M12 guidelines, increasing the use of mass spectrometry for pharmacokinetic studies, plasma protein binding analysis, and low-level drug quantification in complex biological samples. This trend is driving widespread adoption of advanced LC-MS/MS and GC-MS systems across pharmaceutical, clinical, and contract research laboratories globally.

To know about the assumptions considered for the study download the pdf brochure

The competitive landscape for the mass spectrometry market is composed of some strong players that acquire a major share of the market, while at the same time, some of the SME's hold a measurable position in the market. Major players that operate in the mass spectrometry market are Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Waters Corporation (US), Bruker Corporation (US), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US)  Jeol, Ltd. (Japan), Jasco (Japan), Teledyne Technologies Incorporated (US), and MKS Instruments (US).

The main growth strategies used by leading companies in this market include product approvals and launches, acquisitions, collaborations, partnerships, and agreements. Over the past three years, product approvals and launches have been the most popular organic growth strategies adopted by market players seeking to increase their share in the market.

Agilent Technologies, Inc (US)

Agilent Technologies offers a comprehensive portfolio of LC-MS, GC-MS, and ICP-MS in the mass spectrometry market. The company has a strong presence in North America and Europe. Over the last few years, the company has increased its R&D activities with a focus on investing a significant amount of its revenue in R&D, and will continue to have significant research and development expenditures to maintain its competitive position with a continuing flow of innovative, high-quality products and services. The company is also focusing on acquisitions, collaborations, and expansions to maintain its position in the market.

Waters Corporation (US)

Waters Corporation is among the prominent players in the mass spectrometry market. It specializes in liquid chromatography, mass spectrometry (MS), and thermal analysis systems, striving to advance scientific research worldwide. The offering for mass spectrometry covers all major types of analyzers, like quadrupoles and time of flight. Its MS portfolio includes technologies like QuanTof for high-resolution exact mass measurements, StepWave for trace component confirmation, Triwave for complex mixture characterization, and MS E for exact-mass ion spectra from samples. The company focuses on innovation, performance, and usability.

Thermo Fisher Scientific, Inc. (US)

Thermo Fisher is a US-based company that offers a complete and integrated portfolio of solutions and services for laboratory research & analysis, healthcare & clinical science, manufacturing, and other fields. The company operates through four business segments, namely Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The Analytical Instruments business segment offers mass spectrometry products. Thermo Fisher Scientific, being a major player, can be attributed to its extensive portfolio of mass spectrometry equipment used for various applications. It focuses on expanding its product portfolio by introducing new and advanced mass spectrometers for customers in biotechnology, pharmaceuticals, toxicology, forensics, and other fields.

Market Ranking:

The mass spectrometry market is moderately consolidated, with a limited group of global vendors capturing a significant share of revenues through broad instrument portfolios and entrenched installed bases. Thermo Fisher Scientific, Agilent Technologies, and Waters stand out as the principal participants, combining extensive LC-MS/MS product lines with clinical-grade software, assay packages, and service infrastructure that are embedded in hospital, reference, and contract testing laboratories worldwide. A second tier of manufacturers, including Shimadzu and Bruker, contributes meaningfully to market supply through high-performance LC-MS and hybrid MS systems that are increasingly adapted to clinical workflows, often focusing on specific regions or application niches.

Related Reports:

Mass Spectrometry Market by Product [Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software, Services], Inlet Type (LC-MS, GC-MS, ICP-MS, Other Inlet Types), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]